HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giacomo Giacovazzo Selected Research

Peptides (Polypeptides)

1/2021Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer's Disease.
1/2018Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giacomo Giacovazzo Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2017
3Neuroinflammatory Diseases
01/2022 - 01/2021
3Body Weight (Weight, Body)
06/2018 - 06/2013
2Insulin Resistance
11/2021 - 01/2018
2Inflammation (Inflammations)
01/2021 - 01/2018
2Obesity
06/2018 - 06/2013
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022
1Disease Progression
01/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1Motor Neuron Disease (Primary Lateral Sclerosis)
01/2022
1Type 2 Diabetes Mellitus (MODY)
11/2021
1Learning Disabilities (Learning Disability)
11/2021
1Retinal Degeneration
01/2021
1Premature Aging
01/2021
1AIDS-Related Complex (ARC)
01/2021
1Gliosis
01/2020
1Brain Diseases (Brain Disorder)
09/2019
1Feeding and Eating Disorders (Eating Disorder)
06/2018
1Immune System Diseases (Immune Disorders)
01/2018
1Hyperglycemia
01/2018
1Amyloid Plaque
01/2018
1Hyperplasia
01/2018
1Prediabetic State (Prediabetes)
01/2018
1Neuralgia (Stump Neuralgia)
01/2018
1Hyperphagia (Overeating)
06/2013
1Neuroblastoma
06/2013
1Phenylketonurias (Phenylketonuria)
11/2012

Drug/Important Bio-Agent (IBA)

4Amyloid (Amyloid Fibrils)IBA
11/2021 - 01/2018
3Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2018
2Pharmaceutical PreparationsIBA
01/2022 - 06/2013
2Glucose (Dextrose)FDA LinkGeneric
11/2021 - 01/2018
2tau Proteins (tau Protein)IBA
01/2021 - 01/2020
2Peptides (Polypeptides)IBA
01/2021 - 01/2018
2EndocannabinoidsIBA
09/2019 - 06/2013
2LipidsIBA
06/2018 - 01/2018
2Dopamine (Intropin)FDA LinkGeneric
01/2017 - 11/2012
1Trimetazidine (Vastarel)IBA
01/2022
1Flavin-Adenine Dinucleotide (FAD)IBA
11/2021
1Streptozocin (Streptozotocin)FDA Link
11/2021
1AMP-Activated Protein KinasesIBA
11/2021
1Microtubule ProteinsIBA
01/2021
1alpha-SynucleinIBA
01/2021
1Retinaldehyde (Retinal)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2020
1AntigensIBA
01/2020
1NeuropeptidesIBA
06/2018
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2018
1Caveolin 1IBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1GTP-Binding Proteins (G-Protein)IBA
01/2018
1Purinergic P2X7 ReceptorsIBA
01/2018
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2018
11- ((fluoro(methyl)phosphoryl)oxy)- 3- isopropoxypropan- 2- yl oleateIBA
06/2013
1IonomycinIBA
06/2013
1glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
06/2013

Therapy/Procedure

2Therapeutics
01/2020 - 06/2018
1Intravenous Administration
01/2020
1Immunotherapy
01/2020
1Diet Therapy (Therapy, Diet)
01/2018
1Caloric Restriction
01/2018